Extensive Crosstalk between O-GlcNAcylation and Phosphorylation Regulates Akt Signaling

• Shuai Wang ,

  Contributed equally to this work with: Shuai Wang, Xun Huang

  Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Xun Huang ,

  Contributed equally to this work with: Shuai Wang, Xun Huang

  Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Danni Sun,

  Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Xianliang Xin,

  Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Qiuming Pan,

  Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Shuying Peng,

  Affiliation Laboratory of Mass Spectrometry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Zhongjie Liang,

  Affiliation Center for Drug Discovery and Design, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Cheng Luo,

  Affiliation Center for Drug Discovery and Design, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Yiming Yang,

  Affiliation Laboratory of Mass Spectrometry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Hualiang Jiang,

  Affiliation Center for Drug Discovery and Design, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Min Huang,

  Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Wengang Chai,

  Affiliations Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China, Glycosciences Laboratory, Faculty of Medicine, Imperial College London, Harrow, United Kingdom

  ⨯
• Jian Ding ,

  * E-mail: mygeng@mail.shcnc.ac.cn (MG); jding@mail.shcnc.ac.cn (JD)

  Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯
• Meiyu Geng

  * E-mail: mygeng@mail.shcnc.ac.cn (MG); jding@mail.shcnc.ac.cn (JD)

  Affiliation Division of Antitumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

  ⨯